EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation

Xunliang Li iD, Wenman Zhao, Li Zhao, Tongxin Sun, Haifeng Pan, Deguang Wang

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Xunliang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Prediabetic State, Cardiovascular Diseases, Primary Prevention, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiovascular disease (CVD) risk assessment is essential for guiding preventive strategies in populations with diabetes and prediabetes. The American Heart Association's Predicting Risk of CVD Events (PREVENT) equations, introduced in 2023, were developed to address limitations of previous risk assessment tools, including the 2013 Pooled Cohort Equations (PCEs). We compared cardiovascular risk estimates and subsequent statin eligibility using these equations in US adults with prediabetes and diabetes. Materials and Methods Using nationally representative data from the National Health and Nutrition Examination Survey (NHANES) 2013–2020, we analysed 8693 participants aged 40–75 years without known CVD, representing ~104 million US adults. We estimated the 10‐year risk of atherosclerotic CVD (ASCVD), heart failure (HF), and CVD using the PREVENT equations and PCEs, and assessed statin eligibility based on the 2019 American College of Cardiology/American Heart Association and 2024 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines.

Results

The PREVENT equations consistently estimated lower 10‐year ASCVD risk compared with PCEs across all groups. In the diabetes population, 10‐year ASCVD risk was 8.0% (95% CI, 7.7–8.4) using the full PREVENT equation versus 15.7% (95% CI, 14.9–16.4) using PCEs. Similarly, in prediabetes, the risk was 4.0% (95% CI, 3.7–4.2) versus 7.5% (95% CI, 6.8–8.2). HF risk was particularly elevated in diabetes (9.9%, 95% CI, 9.3–10.4) compared with prediabetes (3.7%, 95% CI, 3.4–4.0) and no diabetes/prediabetes (2.8%, 95% CI, 2.7–3.0). When applying 2024 KDIGO guidelines, statin eligibility decreased from 81.6% to 56.5% in diabetes and from 32.5% to 11.8% in prediabetes when using PREVENT versus PCEs. Less than half of statin‐eligible individuals were receiving treatment.

Conclusions

The PREVENT equations estimate substantially lower ASCVD risk compared with PCEs in diabetes and prediabetes populations. These differences substantially impact statin eligibility under current guidelines. The PREVENT equations offer a more comprehensive framework that may better reflect contemporary risk profiles, potentially improving targeted preventive strategies in these high‐risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prediabetic StateCardiovascular DiseasesPrimary PreventionDiabetes MellitusHumansMiddle AgedMaleFemaleAgedUnited StatesAdultRisk AssessmentNutrition SurveysHydroxymethylglutaryl-CoA Reductase InhibitorsHeart Disease Risk Factors

Stichwörter der Autor:innen

cardiovascular diseasepopulation studyprimary caretype 2 diabetes

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Institute of Kidney Disease, Inflammation & Immunity Mediated Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
  • School of Nursing, Anhui Medical University, Hefei, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.

ORCID-Profile: Xunliang Li

Zitieren

APA

Li, X., Zhao, W., Zhao, L., Sun, T., Pan, H., & Wang, D. (2025). Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70043

Vancouver

Li X, Zhao W, Zhao L, Sun T, Pan H, Wang D. Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.70043

BibTeX
@article{Li2025,
  author = {Li, Xunliang and Zhao, Wenman and Zhao, Li and Sun, Tongxin and Pan, Haifeng and Wang, Deguang},
  title = {Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.70043}
}
Kostenlos starten →